Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets
Tl. Clemens et al., Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets, BR J PHARM, 134(6), 2001, pp. 1113-1136
The cloning of the so-called 'parathyroid hormone-related protein' (PTHrP)
in. 1987 was the result of a long quest for the factor which, by mimicking
the actions of PTH in bone and kidney, is responsible for the hypercalcemic
paraneoplastic syndrome, humoral calcemia of malignancy. PTHrP is distinct
from PTH in a number of ways. First, PTHrP is the product of a separate ge
ne. Second, with the exception of a short N-terminal region, the structure
of PTHrP is not closely related to that of PTH. Third, in contrast to PTH,
PTHrP is a paracrine factor expressed throughout the body. Finally, most of
the functions of PTHrP have nothing in common with those of PTH. PTHrP is
a poly-hormone which comprises a family of distinct peptide hormones arisin
g from post-translation al endoproteolytic cleavage of the initial PTHrP tr
anslation products. Mature N-terminal, mid-region and C-terminal secretory
forms of PTHrP are thus generated, each of them having their own physiologi
c functions and probably their own receptors. The type I PTHrP receptor, bi
nding both PTH(1-34) and PTHrP(1-36), is the only cloned receptor so far. P
THrP is a PTH-like calciotropic hormone, a myorelaxant, a growth factor and
a developmental regulatory molecule. The present review reports recent asp
ects of PTHrP pharmacology and physiology, including: (a) the identificatio
n of new peptides and receptors of the PTH/PTHrP system; (b) the recently d
iscovered nuclear functions of PTHrP and the role of PTHrP as an intracrine
regulator of cell growth and cell death; (c) the physiological and develop
mental actions of PTHrP in the cardiovascular and the renal glomerulovascul
ar systems; (d) the role of PTHrP as a regulator of pancreatic beta cell gr
owth and functions, and, (e) the interactions of PTHrP and calcium-sensing
receptors for the control of the growth of placental trophoblasts. These ne
w advances have contributed to a better understanding of the pathophysiolog
ical role of PTHrP, and will help to identify its therapeutic potential in
a number of diseases.